Insiders FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
21.55 ^USD	+0.14%		+0.14%	+124.25%

Jun. 04	Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete	MT
Jun. 04	Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday	Mar. 19	MT
Fusion Pharmaceuticals Inc. Announces Board Changes	23-10-16	CI
Fusion Pharmaceuticals Appoints Dmitri Bobilev as Chief Medical Officer	22-11-07	CI
Fusion Pharmaceuticals Inc. Announces Executive Changes	22-04-13	CI
Insider Sell: Fusion Pharmaceuticals	22-03-08	MT
Insider Sell: Fusion Pharmaceuticals	22-02-17	MT
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development	22-01-10	PR
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development	22-01-10	CI
Fusion Pharmaceuticals Names Christopher Leamon as Chief Scientific Officer	21-11-03	MT
Fusion Pharmaceuticals Inc. Appoints Christopher Leamon as Chief Scientific Officer	21-11-02	CI
Fusion Pharmaceuticals : Names Mohit Rawat as President and Chief Business Officer	21-09-29	MT
Fusion Pharmaceuticals Appoints Mohit Rawat as President and Chief Business Officer	21-09-28	CI
Fusion Pharmaceuticals Inc. Appoints Eric S. Hoffman as Senior Vice President, Business Development	21-09-21	CI
Fusion Pharmaceuticals Inc. Appoints Isabelle Dussault as Senior Vice President, Research	21-06-07	CI
Fusion Pharmaceuticals Appoints Donald Bergstrom to Board of Directors	21-04-01	CI
Fusion Pharmaceuticals Appoints Philina Lee to Its Board of Directors	21-02-11	CI
Fusion Pharmaceuticals Inc. Appoints Barbara Duncan as Chairperson of the Board of Directors	20-11-02	CI
Fusion Pharmaceuticals Appoints Maria Stahl as Chief Legal Officer	20-09-29	CI
Fusion Pharmaceuticals Appoints James J. O’Leary, M.D. as Chief Medical Officer	20-03-23	CI
Fusion Pharmaceuticals Announces Appointment of Steven Gannon to Board of Directors and Chair of Audit Committee	20-03-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders FUSN PHAR

Equities

FUSN

CA36118A1003

Insiders

Filters